Diagnostic Value of 3.0 T Magnetic Resonance Imaging in Active Crohn's Disease

Li-Li Fu1, Xiao-Zhao Zhuang1, Chang-Qing Li1

  • 1Department of Radiology, Hainan Qionghai Traditional Chinese Medicine Hospital, Qionghai 571400, China.

PubMed
Abstract

Insights

3.0 Tesla Magnetic Resonance Enteroclysis (MRE) effectively diagnoses active Crohn's disease (CD). This advanced imaging offers high accuracy, sensitivity, and specificity, showing significant clinical value for CD assessment.

Area of Science:

  • Gastroenterology
  • Radiology
  • Medical Imaging

Background:

  • Magnetic Resonance Enteroclysis (MRE) is a key diagnostic tool for Crohn's disease (CD).
  • 3.0 Tesla (3.0 T) Magnetic Resonance (MR) offers enhanced signal-to-noise ratio and faster acquisition times compared to lower field strengths.

Purpose of the Study:

  • To retrospectively evaluate the diagnostic performance of 3.0 T MR imaging in identifying active Crohn's disease.

Main Methods:

  • 48 patients with confirmed Crohn's disease underwent both double-balloon enteroscopy and 3.0 T MRE.
  • MRE findings (arterial/venous phase signals, bowel wall/lumen characteristics) were analyzed.
  • Diagnostic accuracy, sensitivity, and specificity were calculated against enteroscopy results.

Main Results:

  • 3.0 T MRE identified small bowel CD in 39 of 48 patients, comparable to enteroscopy (P>0.05).
  • Characteristic MRE findings included high arterial phase, low/isointense venous phase signals, bowel wall thickening, and lumen changes.
  • MRE demonstrated 93.75% accuracy, 97.37% sensitivity, and 80.00% specificity for active CD.

Conclusions:

  • 3.0 T MR imaging is a valuable tool for diagnosing active Crohn's disease.
  • The technique shows considerable potential for clinical application in CD management.

Related Concept Videos

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
331
Magnetic Resonance Imaging01:24

Magnetic Resonance Imaging

Magnetic resonance imaging (MRI) is a noninvasive medical imaging technique based on a phenomenon of nuclear physics discovered in the 1930s, in which matter exposed to magnetic fields and radio waves was found to emit radio signals. In 1970, a physician and researcher named Raymond Damadian noticed that malignant (cancerous) tissue gave off different signals than normal body tissue. He applied for a patent for the first MRI scanning device in clinical use by the early 1980s. The early MRI...
5.1K
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
213
Imaging Studies III: Gastrointestinal Motility Studies and Virtual Colonoscopy01:26

Imaging Studies III: Gastrointestinal Motility Studies and Virtual Colonoscopy

This lesson explores three gastrointestinal imaging techniques: radionuclide testing, colonic transit studies, and virtual colonoscopy.
Radionuclide Testing
Radionuclide testing is a sophisticated medical technique for assessing gastrointestinal motility. It focuses on gastric emptying and colonic transit time. Radioactive markers track the movement of food through the digestive system, providing insights into gastrointestinal disorders.
In gastric emptying studies, a meal's liquid and...
74
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
156
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF01:24

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
130